Trial
NCT01165944
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Colorado, Denver
Collaborators
Amylin Pharmaceuticals, LLC.
Condition
Diabetes Mellitus
Intervention
Pramlintide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-26